OrthoSensor Introduces NEW Clinical and Economic Advantages with its Sensors at the American Academy of Orthopaedic Surgeons
Mar 12, 2019, 08:42 ET
DANIA BEACH, Fla., March 12, 2019 /PRNewswire/ -- OrthoSensor, Inc. a leader in sensor-assisted technology today announced its participation at the 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in Las Vegas, NV from March 12-16, booth #434. OrthoSensor will be introducing new proven data about the clinical and economic advantages for surgeons and hospitals with the use of VERASENSE Sensor -Assisted for Total Knee Arthroplasty (TKA), its leading product.
Clinical highlights include:
- VERASENSE helps surgeons balance knees:
- Without VERASENSE, surgeons are only able to balance the knee approximately 50% of the time.1
- Using VERASENSE, results are significantly better (more than 90%).1
- Quantifiably balanced knees perform significantly better clinically in many patient reported outcomes following TKA:
- Increased Satisfaction- 98% at 3-Years2
- Improved Forgotten Joint Score1
- Higher Range of Motion (ROM)3
- Fewer postoperative manipulations for stiffness (MUA)4
Ivan Delevic, President and Chief Executive Officer of OrthoSensor said:
"Our growing body of clinical evidence is proving that VERASENSE helps surgeons address soft tissue balance during TKA and improve patient reported outcomes. Our results also demonstrate VERASENSE can save as much as $725 per patient by lowering variable of post-operative and post-acute care."5
Stop by our booth #434 to learn more about VERASENSE sensor-assisted technology and its global expansion, and for demonstrations of:
- OrthoLogIQ® - data-collection software that quantifies total joint data for the optimization of patient care
- MotionSense™- an in-development wearable patient data-collection sensor*
- Shoulder Sensor - an in-development intraoperative sensor for reverse shoulder arthroplasty**
* Not yet available for commercial sale.
** Not yet available for commercial sale and not cleared by the U.S. FDA
We will also have distinguished guest speakers at daily private luncheons during AAOS exhibit dates discussing the advantages of VERASENSE. Dr. Martin Roche, Chief Medical Officer of Orthosensor, will moderate luncheons. (RSVP).
About OrthoSensor, Inc.
OrthoSensor, Inc., a leader in Sensor-Assisted Technology develops and commercializes intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals. OrthoSensor's intelligent orthopedic devices utilize advanced proprietary sensor and communications technologies, coupled with innovative software products, to facilitate evidence-based decisions in orthopedic surgery – with the goal of improving patient outcomes and potentially reducing the cost of treating musculosketal disease.
1 Golladay et al. (2018, October). Sensor-Assisted Balancing: Does the Surgeon Need the Extra Sense? Podium Presentation, AOA, Perth. Gordon et al. (2018, October). Do Balanced Knees Perform Better Clinically? Podium presentation, ISTA, London.
2 Gutske et al., The Satisfied Total Knee Replacement: 3-Year Multicenter Results. EC Orthopaedics, 2018. Roche et al. (2017, October). Quantified Soft Tissue Balance Utilizing Sensors, and the Effects on Clinical Outcomes in TKA. Podium Presentation. AOA, Adelaide.
3 Chow et al., The Use of Intraoperative Sensors Significantly Increases the Patient-Reported Rate of Improvement in Primary Total Knee Arthroplasty. Orthopedics, 2017.
4 Geller et al., The Use of Electronic Sensor Device to Augment Ligament Balancing Leads to a Lower Rate of Arthrobrosis after Total Knee Arthroplasty. J Arthroplasty, 2017.
5 Conditt et al. (2018, October). Can a Balanced Knee Save Money Post-Operatively? Podium presentation, ISTA, London.
Yvette Cuello
954-592-7799
ycuello@orthosensor.com
SOURCE OrthoSensor, Inc.
Related Links
Share this article